Home Cart Sign in  
Chemical Structure| 979-92-0 Chemical Structure| 979-92-0

Structure of SAH
CAS No.: 979-92-0

Chemical Structure| 979-92-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SAH is an amino acid derivative involved in various metabolic pathways and serves as an intermediate in the synthesis of cysteine and adenosine. SAH also inhibits the METTL3-METTL14 heterodimer complex (METTL3-14), with an IC50 of 0.9 μM.

Synonyms: SAH (S-Adenosylhomocysteine); S-Adenosylhomocysteine; S-(5′-Adenosyl)-L-homocysteine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SAH

CAS No. :979-92-0
Formula : C14H20N6O5S
M.W : 384.41
SMILES Code : N[C@@H](CCSC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3N)O1)O)O)C(O)=O
Synonyms :
SAH (S-Adenosylhomocysteine); S-Adenosylhomocysteine; S-(5′-Adenosyl)-L-homocysteine
MDL No. :MFCD00037388
InChI Key :ZJUKTBDSGOFHSH-WFMPWKQPSA-N
Pubchem ID :439155

Safety of SAH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Description
S-Adenosylhomocysteine (SAH) serves as an amino acid derivative and plays a regulatory role in various metabolic pathways, acting as an intermediate in the synthesis of cysteine and adenosine[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
WRL68 cells 0.25 mM 2 hours To investigate the effect of SAH or DZA pretreatment on TNF-induced cytotoxicity, results showed that SAH or DZA pretreatment significantly enhanced TNF cytotoxicity. PMC1995460
Primary rat hepatocytes 0.25 mM 2 hours To investigate the effect of SAH or DZA pretreatment on TNF-induced cytotoxicity, results showed that SAH or DZA pretreatment significantly enhanced TNF cytotoxicity. PMC1995460
Human umbilical vein endothelial cells (HUVECs) 30 μM 48 hours To investigate the effect of SAHH inhibition on vascular senescence, results showed that SAHH inhibition increased SA β-gal staining and expression of p16, p21, and p53. PMC10400927
DU-145 cells 250 μM 6 days To evaluate the effects of SAH on DU-145 cell proliferation, invasion, migration, and colony formation. Results showed that SAH treatment did not significantly affect DU-145 cell proliferation, invasion, migration, or colony formation. PMC4439874
PC-3 cells 250 μM 6 days To evaluate the effects of SAH on PC-3 cell proliferation, invasion, migration, and colony formation. Results showed that SAH treatment did not significantly affect PC-3 cell proliferation, invasion, migration, or colony formation. PMC4439874

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Fox Chase SCID mice Prostate cancer bone metastasis model Intra-tibial injection 250 μM Single injection, monitored for 4 weeks To evaluate the effect of SAH treatment on PC-3 cell bone metastasis in mice. Results showed that SAH-treated PC-3 cells did not significantly differ from control in the formation of bone lesions. PMC4439874

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.60mL

0.52mL

0.26mL

13.01mL

2.60mL

1.30mL

26.01mL

5.20mL

2.60mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories